最近発症した1型糖尿病患者のインタールイキン-8およびミエロペロキシダースの値上昇
Ghadeer Alhamar1,2, Sara Fallucca1, Sarah J Richardson3
1Unit of Endocrinology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
Diabetes, obesity & metabolism
|September 1, 2025
まとめ
最近発症した1型糖尿病 (T1D) の患者では,インタールイキン-8 (IL- 8) 濃度が臓と血清で上昇しています. 高いIL-8はT1D患者の血糖コントロールの低下と関連しています.
科学分野:
- 免疫学
- 内分泌学
- 糖尿病 研究
背景:
- 1型糖尿病 (T1D) の成人および小児において,循環中のインタールキン-8 (IL- 8) 濃度が上昇していることが報告されています.
- 最近発症したT1Dの臓組織と血清におけるIL-8とその受容体の役割は,まだ完全に解明されていない.
研究 の 目的:
- 臓組織におけるIL-8とIL-8受容体の発現を測定する.
- 最近発症したT1D患者および健康な対照群の血清IL-8およびミエロペロキシダース (MPO) レベルを定量化するために.
主な方法:
- T1Dのドナー (診断から2年以内に) と非糖尿病の対照群から臓のサンプルを採取した.
- 血清は新たにT1Dと診断された42人の患者と11人の健康な対照群から採取された.
- 血清のIL-8およびMPO濃度は,ELISA検査を用いて測定された.
主要な成果:
- T1D患者では,対照群と比較して,IL-8およびIL-8受容体遺伝子発現の有意な増加が観察されました.
- 血清のIL-8濃度は,対照群と比較してT1D患者で有意に高かった.
- ミエロペロキシダース (MPO) 濃度も対照群と比較してT1D患者で上昇した (p=0. 0349).
- IL-8濃度> 62 pg/ mlのT1D患者は,より高いHbA1c (p=0. 015) と血糖値 (p=0. 019) を示した.
結論:
- 最近発症したT1Dにおける臓組織と血清におけるIL-8の上昇を裏付ける結果です.
- 高いIL-8レベルはT1Dの低血糖値と相関する.
- T1Dの病原性におけるIL-8のメカニズム的役割を理解するには,さらなる研究が必要である.
関連する概念動画
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17


